市场调查报告书
商品编码
1368670
胎牛血清市场规模 - 按产品类型(木炭剥离、色谱、外泌体去除)、应用(药物发现、基于细胞的研究)、最终用户和全球预测,2023-2032 年Fetal Bovine Serum Market Size - By Product Type (Charcoal Stripped, Chromatographic, Exosome Depleted), Application (Drug Discovery, Cell-based Research), End-user&, Global Forecast, 2023-2032 |
在多样化细胞培养应用需求不断增长的推动下,胎牛血清市场规模从 2023 年到 2032 年的复合年增长率预计将达到 8.1%。胎牛血清 (FBS) 在生物技术、製药和研究等各个领域都变得非常重要,因为它为最佳细胞生长提供必需的营养素、生长因子和荷尔蒙。随着细胞疗法和再生医学的激增,对高品质胎牛血清的需求也随之加剧。
此外,对细胞培养应用研发活动的大量投资可能会支持整体市场的成长。例如,2023 年 7 月,默克集团在美国和加拿大的生命科学公司 MilliporeSigma 扩大了位于堪萨斯州莱内克萨的实验室设施和製造能力,以生产细胞培养基。此外,一些市场参与者正在专注于开发新的创新产品,以满足不断增长的最终用户需求。
胎牛血清市场按产品类型、应用、最终用户和地区细分。
就产品类型而言,色谱领域的产业价值预计将在 2023 年至 2032 年间获得显着成长。这归因于色谱在分离和纯化胎牛血清成分中的应用不断增加,以确保卓越的产品品质。此外,越来越多地采用先进的色谱技术,如高效液相层析 (HPLC) 和气相层析 (GC),提高了胎牛血清纯化的效率和精度,进一步促进了市场成长。
在应用方面,基于细胞的研究应用领域的胎牛血清市场预计到2032 年将录得可观收入。这一增长可归因于FBS 在细胞培养和各种细胞研究活动(包括细胞生物学)中的日益采用、再生医学和药物开发。对先进细胞疗法的日益关注以及对生命科学新应用的不断探索也将影响该细分市场的成长。
欧洲胎牛血清市场预计将在 2023 年至 2032 年呈现健康成长。生物製药和生物技术产业的强劲以及对研发活动的大量投资正在推动该地区对胎牛血清的需求。强调产品品质和安全的严格监管标准也刺激了优质胎牛血清的采用。此外,慢性病的盛行率不断上升,加上对个人化医疗的日益重视,将增强产业前景。
Fetal Bovine Serum Market size is poised to witness 8.1% CAGR from 2023 to 2032, propelled by increasing demand in diverse cell culture applications. Fetal bovine serum (FBS) has grown profoundly important in various fields, including biotechnology, pharmaceuticals, and research as it provides essential nutrients, growth factors, and hormones for optimal cell growth . With the surge in cell-based therapies and regenerative medicine, the need for high-quality FBS has also intensified.
Additionally, massive investments in the R&D activities of cell culture applications are likely to support the overall market growth. For instance, in July 2023, MilliporeSigma, Merck KGaA's Life Science company in the U.S. and Canada expanded its lab facility and manufacturing capacity to produce cell culture media, in Lenexa, Kansas. Additionally, several market players are focusing on developing new and innovative products for catering to the rising end-user demand.
The fetal bovine serum market is segmented into product type, application, end-user, and region.
With respect to product type, the industry value from the chromatographic segment is projected to gain significant traction between 2023 and 2032. This is attributed to the increasing application of chromatography in isolating and purifying FBS components for ensuring superior product quality. Moreover, the increased adoption of advanced chromatographic techniques, such as high-performance liquid chromatography (HPLC) and gas chromatography (GC), is amplifying the efficiency and precision of FBS purification, further fostering the market growth.
In terms of application, the fetal bovine serum market from the cell-based research application segment is expected to record substantial revenue through 2032. The growth can be attributed to the increasing adoption of FBS in cell culture and various cellular research activities, including cell biology, regenerative medicine, and drug development. The escalating focus on advanced cell-based therapies and the continuous exploration of novel applications in life sciences will also influence the segment growth.
Europe fetal bovine serum market is expected to exhibit healthy growth from 2023 to 2032. The presence of robust biopharmaceutical and biotechnology sector along with substantial investments in R&D activities is fueling the demand for FBS in the region. Stringent regulatory standards for emphasizing product quality and safety are also stimulating the adoption of premium-grade FBS. Moreover, the increasing prevalence of chronic diseases coupled with the growing emphasis on personalized medicine will augment the industry outlook.